Literature DB >> 1741752

Kinetics of the interaction of chymotrypsin with eglin c.

B Faller1, J G Bieth.   

Abstract

The kinetics of binding of recombinant eglin c to bovine pancreatic chymotrypsin was studied by conventional and stopped-flow techniques. With nanomolar enzyme and inhibitor concentrations, the inhibition was fast and pseudo-irreversible (k(assoc.) = 4 x 10(6) m-1.s-1 at 7.4 and 25 degrees C). Reaction of the enzyme-inhibitor complex with alpha 1-proteinase inhibitor, an irreversible chymotrypsin ligand, resulted in a slow release of free eglin c, which was monitored by electrophoresis (k(dissoc.) approximately 1.6 x 10(-6) s-1, t1/2 approximately 5 days). The proflavin displacement method and a stopped-flow apparatus were used to monitor the association of chymotrypsin with eglin c under a wide range of inhibitor concentration and under pseudo-first-order conditions. At pH 7.4 and 25 degrees C or 5 degrees C, or at pH 5.0 and 25 degrees C, the pseudo-first-order rate constant of proflavin displacement increased linearly with eglin c up to the highest concentration tested, suggesting a one-step bimolecular association reaction: E + I in equilibrium with EI. However, kassoc. is much lower than the rate constant for a bimolecular reaction and its activation energy (66 kJ.mol-1 at pH 7.4 and 78 kJ.mol-1 at pH 5.0) is far too high for a diffusion-controlled step. The enzyme-inhibitor association may therefore occur via a loose pre-equilibrium complex EI* (Ki* much greater than 5 x 10(-4) M) that rapidly isomerizes (k2 much greater than 2 x 10(3) s-1) into an extremely stable final complex (Ki approximately 4 x 10(-13) M). Unlike other proteinase-inhibitor systems, the chymotrypsin-eglin association is virtually pH-independent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1741752      PMCID: PMC1130594          DOI: 10.1042/bj2800027

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  The spectrophotometric determination of the operational normality of an alpha-chymotrypsin solution.

Authors:  G R SCHONBAUM; B ZERNER; M L BENDER
Journal:  J Biol Chem       Date:  1961-11       Impact factor: 5.157

2.  Binding of porcine pancreatic secretory trypsin inhibitor to bovine beta-trypsin: a kinetic study.

Authors:  P Ascenzi; G Amiconi; M Bolognesi; E Menegatti; M Guarneri
Journal:  Biopolymers       Date:  1986-12       Impact factor: 2.505

3.  Kinetic evidence for a two-step mechanism for the binding of chymotrypsin to alpha 1-proteinase inhibitor.

Authors:  M Bruch; J G Bieth
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

4.  Kinetics of binding of chicken cystatin to papain.

Authors:  I Björk; E Alriksson; K Ylinenjärvi
Journal:  Biochemistry       Date:  1989-02-21       Impact factor: 3.162

5.  Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G.

Authors:  N J Braun; J L Bodmer; G D Virca; G Metz-Virca; R Maschler; J G Bieth; H P Schnebli
Journal:  Biol Chem Hoppe Seyler       Date:  1987-04

6.  The interaction between alpha-chymotrypsin and pancreatic trypsin inhibitor (Kunitz inhibitor). Kinetic and thermodynamic properties.

Authors:  J P Vincent; M Lazdunski
Journal:  Eur J Biochem       Date:  1973-10-05

7.  Crystal and molecular structure of the inhibitor eglin from leeches in complex with subtilisin Carlsberg.

Authors:  C A McPhalen; H P Schnebli; M N James
Journal:  FEBS Lett       Date:  1985-08-19       Impact factor: 4.124

Review 8.  The behavior and significance of slow-binding enzyme inhibitors.

Authors:  J F Morrison; C T Walsh
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1988

9.  The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.

Authors:  W Bode; E Papamokos; D Musil
Journal:  Eur J Biochem       Date:  1987-08-03

10.  Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor.

Authors:  M Bruch; J G Bieth
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

View more
  1 in total

1.  Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin.

Authors:  D Belorgey; S Dirrig; M Amouric; C Figarella; J G Bieth
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.